Home
overview

SAE Media Group’s 11th Annual Conference
Pharmaceutical Microbiology Europe
January 16 - 17, 2023 |   London, UK
-------------------------------------------------------------------------
SAE is proud to present the 11th Annual Pharmaceutical Microbiology UK Conference in January 2023.

Microbiology is an essential tool for the detection of microorganisms present in biopharmaceutical and drug product manufacture. The field of pharmaceutical microbiology has seen a rapid growth in recent years, this has been in part due to the introduction of alternative, rapid microbiological methods, and the application of automated approaches to microbiology. Together these have provided faster, clearer, and superior data, significantly improving the operational efficiency of laboratories. Alongside these new technologies ever changing regulations such as the impending release of Annex 1 and a globalised aseptic world have meant that the industry is having to re-think many of  the most basic principles.

This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and reduction in operator-product interaction, to the latest technologies in rapid microbiological testing methods and data integrity. The agenda will highlight insightful case studies across these themes, uncovering key developments and the future of pharmaceutical microbiology.

 

This two-day agenda offers you peer-to-peer networking with industry experts and representatives from leading pharmaceutical companies and is the perfect opportunity to maximise the impact of your microbiology labs.

  • Optimise your contamination control strategy with a look-back on the initial impact of Annex 1
  • Learn how to utilise the latest microbiological methods to modernise your contamination control strategy
  • Maximise the data output from your environmental and microbial monitoring with proven strategies and technologies
  • Increase the diversity of your testing methodologies through industry case studies including recombinant factor C and Raman Spectroscopy assays

 

  • Heads of Microbiology
  • Heads of Aseptic Processing
  • Global Quality Directors
  • Heads of GMP Compliance
  • Quality & Compliance Heads
  • Microbiology Senior Specialists
  • Directors of Quality Control Biology
  • Quality Control Managers
  • Quality Assurance Managers
  • Lean Managers
  • Operations Managers
  • Heads of Site Compliance
  • Heads of Sterile Technology
  • Global Microbiology Analytical Experts
  • Cleanroom Managers
  • Regulatory Affairs Managers
  • Production Managers
  • Quality Systems Managers

Previous attendees include:

3dimension Cleanrooms Limited; ADMA Biologics; Amgen; Astra Zeneca; AstraZeneca; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Pharma GmbH & Co.KG; CATAPULT; Charles River EMD; CTL-MAT, LLC; Ecolab Life Sciences; Eli Lilly Italia S P A; Eli Lilly Italia SpA; EUROPAI Uk Ltd; F Ziel GmbH and PHSS; Franz Ziel GmbH; Fresenius Kabi AB; GSK; GSK Vaccines; Jazz Pharmaceuticals; MeiraGTx; Microgenetics; Microgenetics Ltd; Novatek Europe; Novo Nordisk; Oxford BioMedica; Paul Ehrlich Institut; PharmaCircle LLC; Roche Diagnostics Gmbh; Sanofi; STERIS Corporation; Teva; TEVA Runcorn;

Conference programme

8:00 Registration & Coffee

9:00 Chairman's Opening Remarks

9:10 The transition in Pyrogen- and Endotoxin Testing

Ingo Spreitzer

Ingo Spreitzer, Deputy Head, Paul Ehrlich Institut
View Bio

  • Pros and Cons of the current testing strategies
  • “Alternative” approaches using the MAT and rFC
  • Regulations, Requirements and Guidelines
  • Considering the future of the field
  • 9:50 Monocyte Activation Test- Identifying Innate Immune Response

    Sophia Pfeiffer

    Sophia Pfeiffer, Scientist, Boehringer Ingelheim Pharma GmbH & Co.KG
    View Bio

    • Challenges of pyrogen detection
    • Proof of Concept of cryopreserved PBMC based MAT
    • Case study of IIRMI detection
    • Conclusion

    10:30 Morning Coffee

    11:00 rFC Implementation Strategy for Endotoxin Testing

    Lindsey Silva

    Lindsey Silva, Director Microbiology, Genentech
    View Bio

  •  Minimising animal product usage with Recombinant technologies
  •  Reviewing the compendia and regulatory standpoint for rFC
  •  Validation considerations for implementation of rFC as the primary bacterial endotoxin method
  • 11:40 Optimising water monitoring with online water bioburden analysis

    Peter Annel

    Peter Annel, Principal Scientist, Novo Nordisk
    View Bio

  • Implementation and validation of online analysis systems
  • Overcoming challenges with the technology
  • Case Study of Novo Nordisk’s water bioburden monitoring
  • Future outlook for water bioburden analysis systems
     
  • 12:20 Networking Lunch

    13:20 Endotoxin detection challenges associated with the development of a novel VLP

    Callum Scott

    Callum Scott, Technical Transfer and Formulations Development Manager, Allergy Therapeutics UK
    View Bio

    • Development challenges associated with virus-like particles and endotoxin
    • Pyrogen detection strategy for a novel VLP
    • Compliance and regulatory considerations
    • Use of a monocyte activation test (MAT)
     

    14:00 The Pharmaceutical Microbiologist Panel Discussion

  • Recruiting and retaining pharmaceutical microbiologists in the biopharma industry.
  • The role of the pharmaceutical microbiologist on the shop floor and in investigations.
  • Mentoring and providing incentives for the pharmaceutical microbiologist in the industry
  • Developing a pipeline of pharmaceutical microbiologists for the industry
  • Jim Polarine Jr.

    Jim Polarine Jr., Senior Technical Service Manager, STERIS Corporation
    View Bio

    Alexander Stoll

    Alexander Stoll, Vice President, Head of Competence Center Microbiology and Aseptic Techniques, Fresenius Kabi
    View Bio

    Lindsey Silva

    Lindsey Silva, Director Microbiology, Genentech
    View Bio

    14:40 Data Integrity – Challenges in microbiology testing

    Di Morris

    Di Morris, Clinical Development Auditor, AstraZeneca
    View Bio

  •  First principles of data integrity, assurance of data consistency and  accuracy throughout its life cycle
  • Definitions, five essential concepts explained – Assuring data is Attributable, Legible, Contemporaneous, Original, and Accurate
  • Focus: Handling qualitative and quantitative Microbiological data,
  • How to avoid Issues in data integrity
  • 15:20 Afternoon Tea

    15:50 Optimising utilisation of automated colony counting systems in the QC lab

    Sven Deutschmann

    Sven Deutschmann, Head of Global ASAT Adventitious Agent Testing & Alternative Microbiological Methods, Roche Diagnostics GmbH
    View Bio

  • Strategic approaches to evaluating alternative systems
  • Eliminating wait time for near real time release
  • Strengthening industry collaboration to reduce wasted time and money
  • Case Study benefits from implementation at Roche
  • 16:30 Maximising the Output of Automated Environmental Monitoring

    Jan-Jaap Schot

    Jan-Jaap Schot, Associate Director - Site Microbiology Lead, MSD

  • Optimising EM with automation and RMM
  • Increasing your understanding your facilities risk with RT monitoring
  • Maximising data integrity with Automated Environmental Monitoring 
  • Practical and profitable reasons to employ automated EM
  • 17:10 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    9:10 Transformations in Contamination Control Strategies by Annex 1

    James L Drinkwater

    James L Drinkwater, Head of GMP compliance and Aseptic Processing support, Franz Ziel GmbH
    View Bio

  • Applying the revised ICHQ9 QRM principles to a CCS and consideration on Life cycle strategies 
  • CCS implementation experiences following publication of Annex 1 – Case study examples
  • New GMP requirements that make take longer to implement than the default period and how to manage these challenges.
  • Areas where clarity of regulatory expectations still need interpretation to apply in a CCS.
     
  • 9:50 Analysis of the first months of Annex 1 for audit readiness

    Nigel Cryer

    Nigel Cryer, Deputy Director Quality Audits, Sanofi

  • Strategic approaches to analysing your compliance
  • Overcoming challenges that Annex 1 have presented
  •  Ensuring compliance with correct preparation
  •  Improving constantly- How to stay ahead of regulatory changes in the future
     
  • 10:30 Morning Coffee

    11:00 Evaluating the impact of Annex 1’s release so far

    Andrew  Hopkins

    Andrew Hopkins, Director, Audit Readiness, Abbvie

  • Analysing the effectiveness of planning for Annex 1
  • Maximising collective understanding with industry case studies 
  • Eliminating remaining challenges for full compliance
  • Improving preparation for other changes
     
  • 11:40 A discussion on the impact of Annex 1 since publication, benchmarking across the industry

  •  Successes Annex 1 how implementation has improved contamination control
  • Challenges faced during initial implementation period 
  • Delving into the impact in Annex 1 has had
  • Moving forward, what are the next steps before final compliance?
  • James L Drinkwater

    James L Drinkwater, Head of GMP compliance and Aseptic Processing support, Franz Ziel GmbH
    View Bio

    Nigel Cryer

    Nigel Cryer, Deputy Director Quality Audits, Sanofi

    Andrew  Hopkins

    Andrew Hopkins, Director, Audit Readiness, Abbvie

    Di Morris

    Di Morris, Clinical Development Auditor, AstraZeneca
    View Bio

    12:20 Networking Lunch

    13:20 The revised Annex 1 – a manufacturers perspective

    Alexander Stoll

    Alexander Stoll, Vice President, Head of Competence Center Microbiology and Aseptic Techniques, Fresenius Kabi
    View Bio

  • Monitoring (draft) Annex 1 requirements throughout the consultation processes
  • Defining a globally harmonized concept for the Contamination Control Strategy (CCS)
  • How preparation efforts did support global implementation
  • Surprises and/or new elements in the final version?
  • 14:00 How to Implement Annex 1 in the Drug Substance World - A Consensus

    Session reserved for BioPhorum

    Session reserved for BioPhorum, , BioPhorum

  • Understanding the differences in guidance and principles for annex 1 application to sterile drug product manufacture and low bioburden drug substance.
  • How best to utilise the Annex 1 guidance where it can be applied to low bioburden biologic intermediates
  • Maximising product quality and patient safety with by ensuring Annex 1’s correct interpretation
  • 14:40 Global approaches to microbiological testing

    Christoph Hansy

    Christoph Hansy, Associate Director, Takeda*
    View Bio

  •  Drawbacks and challenges of the current testing strategies
  • Transforming global pharmaceutical microbiology with harmonised regulations
  • Strengthening a CCS with novel global approaches
  • Case Study benefits from Takeda’s site implementation
  • 15:20 Afternoon Tea

    15:50 A roadmap to fully automated drug manufacture

    Carl-Helmut Coulon

    Carl-Helmut Coulon, Smart Automation, INVITE GmbH
    View Bio

  •  Disruptive potential of automation within Microbiology Testing
  •  No-touch transfer of materials into the classified area
  •  Robotics Systems with built-in self-awareness, audit-trail and performance verification
  • 16:30 Strengthening Microbial Control Strategies for CGT manufacture

    Vicky Stoyel

    Vicky Stoyel, Senior QA Officer, Oxford BioMedica
    View Bio

  • Complying with GMP regulations for CGT manufacture
  • Differences to be considered for CGT manufacture vs traditional Methods
  •  Developing a specific CCS for CGT manufacture
  • Optimizing microbial control from a QRM perspective
  • 17:10 A Contamination Control Strategy Approach in ATMP Cleanrooms

    Jim Polarine Jr.

    Jim Polarine Jr., Senior Technical Service Manager, STERIS Corporation
    View Bio

  • How to control hard to proactively prevent contamination from viruses, spores and vegetative bacteria
  • Recent case studies from the past few months in cell and gene therapy and compounding pharmacies will be discussed in relation to incubators and pass thru decon
  • Published data will also be covered to convey effective methods in control bioburden into the cleanrooms and BSCs
  • This presentation well be a holistic approach to controlling bioburden from entering cleanrooms and BSCs
  • 17:50 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Alexander Stoll

    Alexander Stoll

    Vice President, Head of Competence Center Microbiology and Aseptic Techniques, Fresenius Kabi
    Callum Scott

    Callum Scott

    Technical Transfer and Formulations Development Manager, Allergy Therapeutics UK
    Carl-Helmut Coulon

    Carl-Helmut Coulon

    Smart Automation, INVITE GmbH
    Christoph Hansy

    Christoph Hansy

    Associate Director, Takeda*
    Di Morris

    Di Morris

    Clinical Development Auditor, AstraZeneca
    Ingo Spreitzer

    Ingo Spreitzer

    Deputy Head, Paul Ehrlich Institut
    James L Drinkwater

    James L Drinkwater

    Head of GMP compliance and Aseptic Processing support, Franz Ziel GmbH
    Jim Polarine Jr.

    Jim Polarine Jr.

    Senior Technical Service Manager, STERIS Corporation
    Lindsey Silva

    Lindsey Silva

    Director Microbiology, Genentech
    Nigel Cryer

    Nigel Cryer

    Deputy Director Quality Audits, Sanofi
    Peter Annel

    Peter Annel

    Principal Scientist, Novo Nordisk
    Sophia Pfeiffer

    Sophia Pfeiffer

    Scientist, Boehringer Ingelheim Pharma GmbH & Co.KG
    Vicky Stoyel

    Vicky Stoyel

    Senior QA Officer, Oxford BioMedica

    Speaker to be Confirmed,

    Alexander Stoll

    Vice President, Head of Competence Center Microbiology and Aseptic Techniques, Fresenius Kabi
    Alexander Stoll

    Born in Germany, Alexander completed his PhD thesis in Microbiology in 2001. After moving to Sweden, he started working for Fresenius Kabi sterile international manufacturing plant in Uppsala. Throughout the years Alexander has been holding different management positions for the Swedish manufacturing plants within QA/QC and as QP. Starting 2012 he had responsibility as a Global Operations QA head, with regional QA and plant QA functions reporting to him. In his current position as VP Competence Center Microbiology & Aseptic Technique he has built a group of subject matter experts working with all manufacturing and compounding sites, setting global standards.

    Andrew Hopkins

    Director, Audit Readiness, Abbvie
    Andrew  Hopkins

    Callum Scott

    Technical Transfer and Formulations Development Manager, Allergy Therapeutics UK
    Callum Scott

    Callum holds a PhD in Molecular Microbiology from Heriot-Watt University. Following a Post-Doctoral Research Fellowship and period as a lecturer in Applied Science, he moved into industry as Vaccine Development Manager with Benchmark Animal Health Ltd. Since 2020, Callum has been a Technical Transfer and Formulations Development Manager with Allergy Therapeutics (UK) Ltd.

    Carl-Helmut Coulon

    Smart Automation, INVITE GmbH
    Carl-Helmut Coulon

    Dr. Coulon started his career at Bayer Cooperation after his PhD in artificial intelligence nearly 25 years ago. 6 years ago he joined INVITE, a joint venture of the Bayer Cooperation with two universities, heading the department for future manufacturing concepts. One of the missions of this group is to “accellerate utilization of modern robots in pharmaceutical industry”

    Christoph Hansy

    Associate Director, Takeda
    Christoph Hansy

    Christoph Hansy

    Associate Director, Takeda*
    Christoph Hansy


    Christoph Hansy has more than 13 years of experience in the pharmaceutical industry. He is currently member of the Global Microbiology Management Team at Takeda and based in Vienna, Austria.
    In his current role he provides subject matter expertise as well as technical leadership on microbiological matters, such as method related projects, microbial control strategies, and contamination/investigation support in a global role. During his career he has undergone several company integration programs and was therefore able to gather multiple insights in different contamination/microbiological control strategies.
    Since 2017 he is involved in the development, implementation and sustain phases of a global contamination control program.
     

    Di Morris

    Clinical Development Auditor, AstraZeneca
    Di Morris

    Di is qualified with MRSC Chemistry and Post Graduate Diploma Industrial Pharmaceutical Science and is a Qualified Person under permanent provisions since 1993.
    Di has worked in the pharmaceutical industry for over 40 years this includes a number of years as a Medicines Inspector for the MHRA. Di has worked in the areas of Quality Control (Chemistry and Microbiology), Quality Assurance, Regulatory Affairs and Compliance Auditing and has worked with a wide range of dosage forms including sterile products, biological, and non-sterile dosage forms.
     

    Ingo Spreitzer

    Deputy Head, Paul Ehrlich Institut
    Ingo Spreitzer

    My former research topics (Lectins) and immune-activating components of bacteria introduced me to preparation /purification and bioassays, which until today influences my work on immune-activating / pyrogenic substances. I started at the PEI 2001 with the development and validation of the Monocyte activation test (MAT).
    My current duties as deputy at the PEI are drug QC by LAL (all methods) and Pyrogen testing (former rabbit pyrogen test, now replaced by MAT) and scientifically the exploration of the MAT. Our actual interests are drugs with intrinsic pyrogenicity, Outer membrane vesicles, synergistic effects and low Endotoxin recovery (LER).
     

    James L Drinkwater

    Head of GMP compliance and Aseptic Processing support, Franz Ziel GmbH
    James L Drinkwater

    Ex-Chairman, honorary member of the PHSS: Pharmaceutical and Healthcare Sciences Society, a Not-For-Profit educational platform for GxP and current leader of PHSS special interest groups on Aseptic processing and Biocontamination. PHSS Co-lead of Annex 1 revision (sterile medicinal product manufacturing) focus group and Contamination Control Strategy (CCS) Guidance initiative. James is also the current Head of GMP Compliance at Franz Ziel GmbH and actively involved In Pharmaceutical, Biologics and ATMP product manufacturing projects. Based in the UK James has a global support role.

    Jim Polarine Jr.

    Senior Technical Service Manager, STERIS Corporation
    Jim Polarine Jr.

    Jim Polarine Jr.

    Senior Technical Service Manager, STERIS Corporation
    Jim Polarine Jr.

    Mr. Polarine is a senior technical service manager at STERIS Corporation. He has been with STERIS Corporation for twenty years. His current technical focus is microbial control in cleanrooms and other critical environments. Mr. Polarine is a 2019 PDA Michael S. Korczynski Award recipient. He has lectured in North America, Europe, Middle East, Asia, and Latin America on issues related to cleaning and disinfection, microbial control in cleanrooms and validation of disinfectants. Mr. Polarine is a frequent industry speaker and published several PDA book chapters and articles related to cleaning and disinfection and contamination control. He is active on the PDA’s COVID-19 Task Force and the PDA’s Microbial Excursions Task Force. He was a co-author on PDA’s Technical Report #70 on Cleaning and Disinfection. Mr. Polarine teaches industry regulators with FDA, MHRA, HPRA, ANVISA, and ANMAT as well as the pharmaceutical, biotech, and medical device industries at the PDA and the University of Tennessee. Mr. Polarine currently teaches the cleaning and disinfection course as part of the PDA Aseptic Processing Course and at the University of Tennessee Parenteral Medications Course. Mr. Polarine is current President for the PDA Missouri Valley Chapter and Technical Coordinator for the IEST. Mr. Polarine graduated from the University of Illinois with a Master of Arts in Biology. He previously worked as a clinical research coordinator with the Department of Veterans Affairs in St. Louis, MO and as a biology and microbiology instructor at the University of Illinois. His main hobby is storm chasing and is very active in tornado research and tornado safety.

    Lindsey Silva

    Director Microbiology, Genentech
    Lindsey Silva

    Lindsey Silva, Ph.D. is a Director, Microbiology in Analytical Sciences at Genentech, a Member of the Roche Group. Our team is responsible for driving QC network analytical innovation and QC microbiology solutions. Dr. Silva was previously responsible for virus clearance studies and development of virus testing technologies to ensure viral safety of biologics. Dr. Silva received her Bachelor of Science in Biology from UC Irvine and Ph.D. in Microbiology and Molecular Genetics from Harvard Medical School. Committed to diversity and inclusion, Dr. Silva co-leads the SACNAS professional chapter at Genentech and is a board member of the non-profit ADDSTEAM.

    Lindsey Silva

    Director Microbiology, Genentech
    Lindsey Silva

    Nigel Cryer

    Deputy Director Quality Audits, Sanofi
    Nigel Cryer

    Peter Annel

    Principal Scientist, Novo Nordisk
    Peter Annel

    DVM in 1983. worked with microbiology since 1984. With Novo Nordisk since 1996, principal scientist since 2004. Worked in micro-QC, API production and product development, providing support and troubleshooting to micro-labs and API and FP production departments on microbial issues as well as training in general microbiology, aseptic behaviour etc.
    Member of EDQM group 1, Microbiology, since 2011.
     

    Session reserved for BioPhorum

    , BioPhorum
    Session reserved for BioPhorum

    Sophia Pfeiffer

    Scientist, Boehringer Ingelheim Pharma GmbH & Co.KG
    Sophia Pfeiffer

    As Lead Scientist in the Microbiology Group at Boehringer Ingelheim Biberach, Sophia is responsible for screening, selection and successful implementation of state-of-the-art technologies in microbiology routine labs. Her main task is to drive the transformation of the labs in terms of automation, innovation and digitalization. Sophia has worked across multiple disciplines along her career including Research and Development, Quality Control and Microbiology. Sophia holds a Master’s Degree in Pharmaceutical Biotechnology by the University of Ulm, Germany.

    Sven Deutschmann

    Head of Global ASAT Adventitious Agent Testing & Alternative Microbiological Methods, Roche Diagnostics GmbH
    Sven Deutschmann

    Sven Deutschmann studied biology at the University of Brunswick where he obtained his PhD in cell culture technology. His current position is Head of Global Analytical Science and Technology “Adventitious Agents Testing & Alternative Microbiological Methods” within Global QC.

    Besides his internal responsibilities Sven is member of the German Pharmacopeia Commission, and the Microbiology Committee of the German Pharmacopeia Commission as well as Germany’s representative in the Working Parties “Bacterial Endotoxins”, “Mycoplasmas” (whose chairman he is) and Expert Group 1 “Biological Methods and Statistical Analysis” (whose chairman he is) of the European Pharmacopeia Commissions in Strasbourg, France. In 2009 he was appointed as commissioner of the Central Commission for Biological Safety, a brains trust of the Federal Office of Consumer Protection and Food Safety. In addition, Sven is chairman of the Advisory Board of the ECA “Pharmaceutical Microbiology” Interest Group.
     

    Vicky Stoyel

    Senior QA Officer, Oxford BioMedica
    Vicky Stoyel

    Vicky Stoyel qualified as a Microbiologist from Bristol University and worked in this field for several years. She eventually became a Site Microbiologist working with sterile, radioactive pharmaceuticals. More recently she has moved to Oxford Biomedica in a Quality Assurance role and is involved in project delivery. She is currently working on a new filling isolator for ATMPs and responsible for contamination controls.

    Supporters

    VENUE

    Copthorne Tara Hotel

    Scarsdale Place, Kensington, London, United Kingdom

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Past Attendees List

    Download

    Brochure

    Download

    Short Programme

    Download

    Full Programme

    Download

    Conference Co-chair Letter

    Download

    Media Partners


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Farmavita

    Supporters
    https://farmavitar.com

    FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.


    MedTube

    Supporters
    https://medtube.net/



    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    American Pharmaceutical Review

    Supporters
    http://www.americanpharmaceuticalreview.com

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy


    Rapid Microbiology.com

    Supporters
    https://www.rapidmicrobiology.com

    rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions. To keep up-to-date with the latest microbiology news get our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.


    World Pharma News

    Supporters
    http://www.worldpharmanews.com/



    SciDoc Publishers

    Supporters
    http://www.scidoc.org

    SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    IPI

    Supporters
    http://www.ipimediaworld.com

    IPI – International Pharmaceutical Industry Established by professionals with over 30 years experience in the Pharmaceutical and Life sciences publishing sectors. We have identified the needs of these dynamic industries, and have listened carefully to our readers and advertisers. With strong collaboration between Pharmaceutical and Life sciences Industry Associations we have created a global distribution network. We give you a promise to become a reliable extension of your marketing and communication arm. If necessary we will integrate our expertise with your needs. Incorporating new and innovative communication methods we will help to highlight your expertise.


    Genetic Engineering News

    Supporters
    http://www.genengnews.com

    Genetic Engineering & Biotechnology News (GEN) is the most authoritative and widely read biotechnology news publication in the world.Published 21 times a year,GEN's unique news and technology focus include the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drugs and biomarker discovery, bioprocessing, clinical research, molecular diagnostics and biobusiness. For a free subscription go to: http://www.genengnews.com/subscriptions.aspx


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out